MedPath

APO-RILUZOLE

APO-RILUZOLE

Approved
DIN Number

02352583

Drug Class

Human

Market Date

Sep 25, 2012

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02352583
AIG Number0141861001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX02 RILUZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:44.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

RILUZOLEActive
Strength: 50 MG
Monograph: RILUZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.